Diaverum presents new corporate logo at ASN Kidney Week

Munich/San Diego – 5 November 2015: Diaverum, one of the leading renal care providers worldwide, is presenting its service portfolio and medical studies at the ASN Kidney Week in San Diego, California. At the exhibition, the company launches its new logo to an external audience.

Evolving the Diaverum logo

“We are putting the patient in the centre of everything we do and the new logo is now reflecting this focus,” explains Christina Sterner at the start of the exhibition of ASN Kidney week. “The icon, that we added to the Diaverum word mark, describes our dynamic and caring approach. It symbolises the process of revitalisation, that our patients are undergoing during their treatment, and our commitment to provide the best care”.

The new unique icon consists of a “p” for patient and a “d” for Diaverum joined together in a modern and lively manner. Coloured in the typical Diaverum orange and combined with the Diaverum word mark, it stands for the dedication to patient focus as well as constant development.

Diaverum started as Gambro Healthcare more than 20 years ago and has been operating under the name “Diaverum” since 2008. Globally Diaverum is known for its excellent medical staff and the warm and friendly atmosphere that is it creating in its clinics, with the aim of providing a revitalising experience to renal patients. “The Diaverum orange is already transporting our key values competent, inspiring and passionate. With the new logo we are taking the next step in communicating our brand to renal patients, their relatives, the medical community and our business partner in 20 countries worldwide,” Christina Sterner adds.

The new logo will be rolled out to all Diaverum clinics and offices over the next months.

Diaverum posters at ASN

On Friday, 6 November, 10-12am, and Saturday, 7 November, 10-12am, the Diaverum physicians Dr. Staffan Schön and Dr. Marietta Török, will present the following posters at ASN:

  • FR‑PO648: Glucose Targets for Preventing Diabetic Kidney Disease and Its Progression: A Meta-Analysis
  • SA‑PO739: Neurocognitive Functioning and Association with Clinical Outcomes in Adults with End-Stage Kidney Disease: The COGNITIVE-HD Study
  • SA‑PO821: Continuous Erythropoiesis Receptor Activator (CERA) for the Anemia of Chronic Kidney Disease (CKD): A Meta-Analysis of Randomized Controlled Trials

The Diaverum booth is located in the main exhibition hall, booth No 430.